You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer ⊕

found 2025 › Oct › 30 (Thu) @ 15:10 UTC

a story from The Guardian ⚠️ › International

US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs

Novo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Met…